Highlights: Traditional biomarkers used in kidney transplant care lack sensitivity and specificity for early detect

Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less invasive and reliable...

Discover how cell-free DNA sequencing and whole-body MRI provide a breakthrough in detecting occult cancers in pregnant women.

Cell-free DNA (cfDNA) is one of the important biomarkers of liquid biopsy for many malignant cancers like urothelial bladder cancer. However, the

Circulating cell-free plasma telomere length (cf-TL) is a cell-free DNA (cfDNA) that has shown its potential as a biomar

Discover a groundbreaking blood test that detects early signs of heart transplant rejection, offering a non-invasive, cost-effective alternative to...

Canadian researchers unveiled the potential of a non-invasive approach for early sepsis (!--ref1--) detection. h2What is Sepsis/h2 bSepsis/b

Explore how circulating cell-free plasma telomere length (cf-TL) serves as a promising biomarker for heart failure.

Non-invasive imaging tests are transforming sepsis care by enabling early detection, improving outcomes, and saving lives through quicker...

Non-invasive imaging tests are transforming sepsis care by enabling early detection, improving outcomes, and saving lives through quicker...